MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Arterial response to ketanserin and aspirin in patients with advanced peripheral atherosclerosis.
Lower Extremity Arterial Calcification as a Predictor of Coronary Atherosclerosis in Patients with Peripheral Arterial Disease.
[Preliminary analysis of the relationship between peripheral arterial disease and other atherosclerosis markers and diabetic nephropathy].
Vascular fluid mechanics, the arterial wall, and atherosclerosis.
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
Reply to arterial stiffness in patients with peripheral arterial disease.
Peripheral arterial disease.
Inhibition of cyclooxygenase attenuates the blood pressure response to plantar flexion exercise in peripheral arterial disease.
Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.
Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease.
Approach to the patient with peripheral arterial disease.
Peripheral atherosclerosis in patients with arterial erectile dysfunction.
Atherectomy for peripheral arterial disease.
Evaluating peripheral arterial occlusive disease.
Fibrinogen genes and peripheral arterial disease.
Uric Acid and Peripheral Arterial Disease.
Metabolic syndrome and peripheral arterial disease.
Cadmium exposure and incident peripheral arterial disease.
The arterial wall and atherosclerosis.
Cerebral vascular disease, venous and arterial thrombosis.
The contribution of arterial calcification to peripheral arterial disease in pseudoxanthoma elasticum.
ACE inhibitors and peripheral vascular disease.
Letter: Trental and peripheral vascular disease.
Atherosclerosis, peripheral arterial disease and the vascular response to ketanserin.
Platelet activation releases thromboxane A2 and serotonin, which acts on blood vessels through a specific, 5-hydroxytryptamine (5-HT2) receptor. The d...
675KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Arterial response to ketanserin and aspirin in patients with advanced peripheral atherosclerosis.
Lower Extremity Arterial Calcification as a Predictor of Coronary Atherosclerosis in Patients with Peripheral Arterial Disease.
[Preliminary analysis of the relationship between peripheral arterial disease and other atherosclerosis markers and diabetic nephropathy].
Vascular fluid mechanics, the arterial wall, and atherosclerosis.
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
Reply to arterial stiffness in patients with peripheral arterial disease.
Peripheral arterial disease.
Inhibition of cyclooxygenase attenuates the blood pressure response to plantar flexion exercise in peripheral arterial disease.
Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms